Adamax – Research Peptide (Nootropic / Neurotrophic Analog) 

Available sizes: 5mg and 10mg

Adamax is a synthetic next-generation analog of Semax, a well-known heptapeptide derived from the adrenocorticotropic hormone (ACTH 4-7) fragment. It incorporates key structural modifications, including N-terminal acetylation and an adamantane (adamantyl) scaffold, which enhance its lipophilicity, stability, blood-brain barrier (BBB) penetration, and resistance to enzymatic degradation compared to standard Semax. 

These enhancements are designed to provide prolonged activity and amplified effects on neurotrophic pathways in research models, making Adamax a potent compound for studying cognitive and neuroprotective mechanisms. 

Key Research Areas and Observed Effects (Preclinical/In Vitro)

•  Cognitive Enhancement & Executive Function: Supports focus, mental clarity, learning, memory consolidation, and task endurance without typical stimulant-like crashes. 

•  Neuroprotection & Resilience: Promotes neuron protection against oxidative stress, supports recovery in models of neural injury or stress, and enhances overall brain resilience. 

•  BDNF & Neuroplasticity: Upregulates brain-derived neurotrophic factor (BDNF) expression and increases sensitivity of TrkB receptors in the hippocampus, aiding neurogenesis, synaptic plasticity, and long-term neural adaptability. 

•  Mood, Motivation & Stress Response: Investigated for potential benefits in mood regulation, stress resilience, and monoaminergic signaling pathways. 

•  Additional Investigated Areas: Energy metabolism in brain cells (e.g., ATP efficiency), endurance in cognitive tasks, and broader neuromodulation. 

For Research Use Only (RUO)